The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Clinical development of liposome based drugs: formulation, characterization, and therapeutic efficacy
Open accessAbstract
Research on liposome formulations has progressed from that on conventional vesicles to new generation liposomes, such as cationic liposomes, temperature sensitive liposomes, and virosomes, by modulating the formulation techniques and lipid composition. Many research papers focus on the correlation of blood circulation time and drug accumulation in target tissues with physicochemical properties of liposomal formulations, including particle size, membrane lamellarity, surface charge, permeability, encapsulation volume, shelf time, and release rate. This review is mainly to compare the therapeutic effect of current clinically approved liposome-based drugs with free drugs, and to also determine the clinical effect via liposomal variations in lipid composition. Furthermore, the major preclinical and clinical data related to the principal liposomal formulations are also summarized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664
Szoka, F., & Papahadjopoulos, D. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.9.4194 · Cited by 2,323
(1999) · Archives of Ophthalmology · doi:10.1001/archopht.117.10.1329 · Cited by 2,192
New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?
Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951
O’Brien, M. E. R., Wigler, N., Inbar, M., Rosso, R., Grischke, E., Santoro, A., Catane, R., Kieback, D. G., Tomczak, P., Ackland, S. P., et al. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh097 · Cited by 1,738
Needham, D., Anyarambhatla, G., Kong, G., & Dewhirst, M. W. (2000) · PubMed · Cited by 746
Complement activation-related pseudoallergy: A new class of drug-induced acute immune toxicity
Szebeni, J. (2005) · Toxicology · doi:10.1016/j.tox.2005.07.023 · Cited by 611
Liposomes: Technologies and Analytical Applications
Jesorka, A., & Orwar, O. (2008) · Annual Review of Analytical Chemistry · doi:10.1146/annurev.anchem.1.031207.112747 · Cited by 569
An overview of liposome lyophilization and its future potential
Chen, C., Han, D., Cai, C., & Tang, X. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.10.024 · Cited by 545
Tumour-targeted nanomedicines: principles and practice
Lammers, T., Hennink, W. E., & Storm, G. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604483 · Cited by 542
Harris, L., Batist, G., Belt, R., Rovira, D., Navari, R., Azarnia, N., Welles, L., Winer, E., & TLC D‐99 Study Group (2002) · Cancer · doi:10.1002/cncr.10201 · Cited by 512
Dromi, S., Frenkel, V., Luk, A., Traughber, B., Angstadt, M., Bur, M., Poff, J., Xie, J., Libutti, S. K., Li, K. C. P., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2443 · Cited by 492
Liposome-based drug delivery in breast cancer treatment
Park, J. W. (2002) · Breast Cancer Research · doi:10.1186/bcr432 · Cited by 469
NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis
Denning, D. W., Lee, J. Y., Hostetler, J. S., Pappas, P., Kauffman, C. A., Dewsnup, D. H., Galgiani, J. N., Graybill, J. R., Sugar, A. M., Catanzaro, A., et al. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90023-x · Cited by 450
Gill, P. S., Wernz, J., Scadden, D. T., Cohen, P., Mukwaya, G. M., von Roenn, J. H., Jacobs, M., Kempin, S., Silverberg, I., Gonzales, G., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.8.2353 · Cited by 438
Zhang, J. A., Anyarambhatla, G., Ma, L., Ugwu, S., Xuan, T., Sardone, T., & Ahmad, I. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.06.009 · Cited by 334
Conventional and Dense Gas Techniques for the Production of Liposomes: A Review
Meure, L. A., Foster, N. R., & Dehghani, F. (2008) · AAPS PharmSciTech · doi:10.1208/s12249-008-9097-x · Cited by 297
Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
Herzog, C., Hartmann, K., Künzi, V., Kürsteiner, O., Mischler, R., Lazar, H., & Glück, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.029 · Cited by 292
Winer, E. P., Berry, D. A., Woolf, S., Duggan, D., Kornblith, A., Harris, L. N., Michaelson, R. A., Kirshner, J. A., Fleming, G. F., Perry, M. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.048 · Cited by 270
Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation.
Rahman, A. M., Yusuf, S. W., & Ewer, M. S. (2007) · PubMed Central · Cited by 267
Protein and peptide drug delivery: Oral approaches
Shaji, J., & Patole, V (2008) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.42967 · Cited by 262
Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial
Meunier, F., Prentice, H. G., & Ringden, O. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/28.suppl_b.83 · Cited by 247
Mills, J. K., & Needham, D. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.08.007 · Cited by 236
Lipoplatin Formulation Review Article
Stathopoulos, G. P., & Boulikas, T. (2012) · Journal of Drug Delivery · doi:10.1155/2012/581363 · Cited by 224
Development of a New Preparation Method of Liposomes Using Supercritical Carbon Dioxide
Otake, K., Imura, T., Sakai, H., & Abe, M. (2001) · Langmuir · doi:10.1021/la010122k · Cited by 193
Fahr, A., Hoogevest, P. V., May, S., Bergstrand, N., & S. Leigh, M. L. (2005) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2005.05.012 · Cited by 189
Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
Bressler, N. M., & Bressler, S. B. (2000) · PubMed · Cited by 160
Nanotechnology and human health: risks and benefits
Cattaneo, A. G., Gornati, R., Sabbioni, E., Chiriva‐Internati, M., Cobos, E., Jenkins, M. R., & Bernardini, G. (2010) · Journal of Applied Toxicology · doi:10.1002/jat.1609 · Cited by 158
Functional reconstitution of influenza virus envelopes.
Stegmann, T., Morselt, H. W. M., Booy, F. P., van Breemen, J. F., Scherphof, G. L., & Wilschut, J. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02556.x · Cited by 158
Glück, R., Mischler, R., Brantschen, S., et al. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116141 · Cited by 156
Nanomedicine: Novel approaches in human and veterinary therapeutics
Irache, J. M., Esparza, I., Gamazo, C., Agüeros, M., & Espuelas, S. (2011) · Veterinary Parasitology · doi:10.1016/j.vetpar.2011.05.028 · Cited by 154
Yarmolenko, P., Zhao, Y., Landon, C. D., Spasojević, I., Yuan, F., Needham, D., Viglianti, B. L., & Dewhirst, M. W. (2010) · International Journal of Hyperthermia · doi:10.3109/02656731003789284 · Cited by 154
White, S. C., Lorigan, P. C., Margison, G. P., Margison, J. M., Martin, F., Thatcher, N., Anderson, H., & Ranson, M. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603345 · Cited by 152
Rodriguez, M. A., Pytlík, R., Kozák, T., Chhanabhai, M., Gascoyne, R. D., Lu, B., Deitcher, S. R., & Winter, J. N. (2009) · Cancer · doi:10.1002/cncr.24359 · Cited by 145
Dragovich, T., Mendelson, D. S., Kurtin, S. E., Richardson, K., Hoff, D. D. V., & Hoos, A. (2006) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-006-0235-4 · Cited by 142
Mross, K. B., Niemann, B., Massing, U., Drevs, J., Unger, C., Bhamra, R. K., & Swenson, C. E. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0825-y · Cited by 137
Krishna, R., Webb, M. S., St.-Onge, G., & Mayer, L. D. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29494-5 · Cited by 129
Liposomal Anthracyclines in Metastatic Breast Cancer: Clinical Update
Rivera, E. (2003) · The Oncologist · doi:10.1634/theoncologist.8-2004-3 · Cited by 128
Therapeutic opportunities for targeted liposomal drug delivery
Allen, T. M., & Moase, E. H. (1996) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00402-4 · Cited by 126
Novel Long-Circulating Lipid Nanocapsules
Hoarau, D., Delmas, P., David, S., Roux, E., & Leroux, J. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000045229.87844.21 · Cited by 121
Banno, B., Ickenstein, L. M., Chiu, G. N. C., Bally, M. B., Thewalt, J. L., Brief, E., & Wasan, E. K. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21988 · Cited by 117
Size of thermosensitive liposomes influences content release
Hossann, M., Wang, T., Wiggenhorn, M., Schmidt, R., Zengerle, A., Winter, G., Eibl, H., Peller, M., Reiser, M. F., Issels, R. D., et al. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.013 · Cited by 114
Characterization of Nebulized Liposomal Amikacin (Arikace ™ ) as a Function of Droplet Size
Li, Z., Zhang, Y., Wurtz, W., Lee, J. K., Malinin, V., Durwas-Krishnan, S., Meers, P. R., & Perkins, W. R. (2008) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2008.0686 · Cited by 112
Pharmacokinetics of paclitaxel-containing liposomes in rats
Fetterly, G. J., & Straubinger, R. M. (2003) · AAPS PharmSci · doi:10.1208/ps050432 · Cited by 112
PREPARATION AND PROPERTIES OF ETHER‐INJECTION LIPOSOMES *
Deamer, D. W. (1978) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1978.tb22027.x · Cited by 111
Fighting Cancer: From the Bench to Bedside Using Second Generation Cationic Liposomal Therapeutics
Campbell, R. B., Ying, B., Kuesters, G. M., & Hemphill, R. L. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21458 · Cited by 107
Clemons, K. V., & Stevens, D. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.899 · Cited by 105
Semple, S. C., Leone, R., Wang, J., Leng, E. C., Klimuk, S. K., Eisenhardt, M. L., Yuan, Z.-N., Edwards, K., Maurer, N., Hope, M. J., et al. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20332 · Cited by 101
Jiskoot, W., Teerlink, T., Beuvery, E. C., & Crommelin, D. J. A. (1986) · Pharmacy World & Science · doi:10.1007/bf01960070 · Cited by 99
Kim, S., & Martin, G. M. (1981) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(81)90264-9 · Cited by 95
Hong, R., & Tseng, Y. (2001) · Cancer · doi:10.1002/1097-0142(20010501)91:9<1826::aid-cncr1203>3.0.co;2-j · Cited by 84
Effect of formulation design and freeze-drying on properties of fluconazole multilamellar liposomes
El-Nesr, O. H., Yahiya, S. A., & El-Gazayerly, O. N. (2010) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2010.07.003 · Cited by 79
Pal, A., Khan, S., Wang, Y.-F., Kamath, N., Sarkar, A., Ahmad, A., Sheikh, S., Ali, S., Carbonaro, D., Zhang, A., et al. (2005) · PubMed · Cited by 79
Immunogenicity and Safety of a Virosomal Hepatitis A Vaccine (Epaxal®) in the Elderly
D’Acremont, V., Herzog, C., & Genton, B. (2006) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.2006.00001.x · Cited by 74
Development of a Novel Method for Formulating Stable siRNA-Loaded Lipid Particles for In vivo Use
Wu, S. Y., Tom, L. N., Liang, M., Chang, H.-I., Davies, N. M., & McMillan, N. A. J. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9766-1 · Cited by 73
Self-citationKanra, G., Marchisio, P., Feiterna‐Sperling, C., Gaedicke, G., Lazar, H., Durrer, P., Kürsteiner, O., Herzog, C., Kara, A., & Principi, N. (2004) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200404000-00005 · Cited by 72
Usonis, V., Bakasénas, V., Valentelis, R., Katiliene, G., Vidzeniene, D., & Herzog, C. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00509-7 · Cited by 72
CO2/water/surfactant ternary systems and liposome formation using supercritical CO2: A review
Lesoin, L., Boutin, O., Crampon, C., & Badens, E. (2011) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2011.01.027 · Cited by 69
Current trends in the production and biomedical applications of liposomes: a review
Uhumwangho, M., & Okor, R. S. (2009) · Journal of Medicine and Biomedical Research · doi:10.4314/jmbr.v4i1.10663 · Cited by 69
Phase II study of liposomal annamycin in the treatment of doxorubicin-resistant breast cancer
Booser, D. J., Esteva, F. J., Rivera, E., Valero, V., Esparza-Guerra, L., Priebe, W., & Hortobágyi, G. N. (2002) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-002-0464-0 · Cited by 67
Drug release characteristics of lipid based benzoporphyrin derivative.
Chowdhary, R. K., Shariff, I., & Dolphin, D. (2003) · PubMed · Cited by 65
Castor, T. P. (2005) · Current Drug Delivery · doi:10.2174/156720105774370195 · Cited by 63
New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers
Gardikis, Κ., Tsimplouli, C., DIMAS, K. S., Micha‐Screttas, M., & Demetzos, C. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.007 · Cited by 57
Recent developments in palliative chemotherapy for locally advanced and metastatic pancreas cancer
Bayraktar, S. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i6.673 · Cited by 55
Controlling Subcellular Delivery to Optimize Therapeutic Effect
Mossalam, M., Dixon, A. S., & Lim, C. S. (2010) · Therapeutic Delivery · doi:10.4155/tde.10.8 · Cited by 54
Arlinghaus, R. B., Lopez‐Berestein, G., Belmont, J. W., Rosenblum, M. G., Sun, T., Stephens, C. L., Monaco, G., Gutiérrez-Puente, Y., & Tari, A. M. (2007) · International Journal of Oncology · doi:10.3892/ijo.31.5.1243 · Cited by 38
Repairing DNA damage in xeroderma pigmentosum: T4N5 lotion and gene therapy.
Zahid, S., & Brownell, I. (2008) · PubMed · Cited by 38
Wasan, K. M., & Lopez‐Berestein, G. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.5.1126 · Cited by 35
Eichhorn, M., Becker, S., Strieth, S., Werner, A., Sauer, B., Teifel, M., Ruhstorfer, H., Michaelis, U., Griebel, J., Brix, G., et al. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.1.2346 · Cited by 30
BLP-25 liposomal vaccine: a promising potential therapy in nonsmall-cell lung cancer
Powell, E. D., & Chow, L. Q. M. (2008) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2.1.37 · Cited by 29
Yu, N. Y., Conway, C., Pena, R. L., & Chen, J. Y. (2007) · PubMed · Cited by 24
Liposomes: Design and Manufacturing
Patil, S. D., & Burgess, D. J. (2005) · CRC Press eBooks · doi:10.1201/9780849350610-12 · Cited by 11
Cited by
Advances and Challenges of Liposome Assisted Drug Delivery
Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,632
Liposomes as nanomedical devices
Bozzuto, G., & Molinari, A. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s68861 · Cited by 2,261
Liposomal Formulations in Clinical Use: An Updated Review
Bulbake, U., Doppalapudi, S., Kommineni, N., & Khan, W. (2017) · Pharmaceutics · doi:10.3390/pharmaceutics9020012 · Cited by 2,156
New developments in liposomal drug delivery
Pattni, B. S., Chupin, V. V., & Torchilin, V. P. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00046 · Cited by 1,600
Liposomes: Structure, composition, types, and clinical applications
Nsairat, H., Khater, D., Sayed, U., Odeh, F., Al Bawab, A., & Alshaer, W. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09394 · Cited by 1,561
Metadata
- Authors
- Yeh, M.-K., Chang, H.-I., & Cheng, M.-Y.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2011-12
- Volume
- 7
- Pages
- 49
- ISSN
- 1176-9114 (ISSN-L)
- 1178-2013
- OpenAlex
- W2108471741
- Cited by
- 801
- References
- 73
- FWCI
- 15.31
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.